Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Change in Inventory: 2016-2024

Historic Change in Inventory for Heron Therapeutics (HRTX) over the last 9 years, with Dec 2024 value amounting to $11.1 million.

  • Heron Therapeutics' Change in Inventory fell 195.27% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.1 million, marking a year-over-year increase of 510.58%. This contributed to the annual value of $11.1 million for FY2024, which is 188.66% up from last year.
  • As of FY2024, Heron Therapeutics' Change in Inventory stood at $11.1 million, which was up 188.66% from -$12.5 million recorded in FY2023.
  • Heron Therapeutics' Change in Inventory's 5-year high stood at $16.9 million during FY2020, with a 5-year trough of -$12.5 million in FY2023.
  • In the last 3 years, Heron Therapeutics' Change in Inventory had a median value of $6.2 million in 2022 and averaged $1.6 million.
  • In the last 5 years, Heron Therapeutics' Change in Inventory soared by 220.43% in 2020 and then crashed by 301.31% in 2023.
  • Over the past 5 years, Heron Therapeutics' Change in Inventory (Yearly) stood at $16.9 million in 2020, then plummeted by 61.76% to $6.5 million in 2021, then dropped by 4.42% to $6.2 million in 2022, then tumbled by 301.31% to -$12.5 million in 2023, then soared by 188.66% to $11.1 million in 2024.